🇺🇸 FDA
Patent

US 11344609

Compositions and methods for treating hemoglobinopathies

granted A61KA61K31/7088A61K35/15

Quick answer

US patent 11344609 (Compositions and methods for treating hemoglobinopathies) held by Beam Therapeutics Inc. expires Mon May 26 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Beam Therapeutics Inc.
Grant date
Tue May 31 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 26 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
34
CPC classes
A61K, A61K31/7088, A61K35/15, A61K35/18, A61K35/28